The relevant medical services in Cyprus are on high alert to address any potential cases of Mpox (monkeypox) that might be detected, despite the low risk of such an occurrence, according to the Director of Medical Services and Public Health Services, Elisavet Constantinou.

Speaking to the Cyprus News Agency (CNA), she stated that five cases have been identified in Cyprus from 2022 until now.

Constantinou emphasised that the Ministry of Health is actively evaluating the country’s preparedness by reviewing available resources and updating protocols. "We assess our readiness on a daily basis", she said, highlighting the importance of staying vigilant. "Since there is a public health emergency alert, we are obligated to address it." She reiterated that only five cases have been recorded in Cyprus since 2022, reflecting the low risk of widespread transmission.

The Ministry of Health is also focusing on preventive measures, she said, adding that vaccinations against mpox are available at adult vaccination centers in all cities across Cyprus. These vaccines can be administered daily, ensuring accessibility for those who wish to be vaccinated.

Furthermore, Constantinou provided guidance for travelers planning to visit regions experiencing mpox outbreaks, primarily in Africa. She recommended that travelers get vaccinated before their trips and take precautions to avoid contact with individuals who may have rashes or symptoms of the disease.

Addressing the country's preparedness, Constantinou confirmed that Cyprus has a sufficient stock of vaccines and pharmaceutical products to manage potential cases. Diagnostic testing for mpox is already being conducted at two centers: the Nicosia General Hospital’s Microbiology Laboratory and the Cyprus Institute of Neurology and Genetics.

While the risk of contracting mpox remains low for those who have not traveled to affected areas, Constantinou urged vulnerable populations, including the elderly and immunocompromised individuals, to take extra precautions and avoid crowded places.